Acorah Software Products - Accounts Production 19.4.300 false true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 12686351 Ms Jane Wragg Miss Nicola Smith Mr Charles Wilkerson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12686351 2024-12-31 12686351 2025-12-31 12686351 2025-01-01 2025-12-31 12686351 frs-core:ShareCapital 2025-12-31 12686351 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 12686351 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 12686351 frs-bus:AbridgedAccounts 2025-01-01 2025-12-31 12686351 frs-bus:SmallEntities 2025-01-01 2025-12-31 12686351 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 12686351 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 12686351 frs-bus:Director1 2025-01-01 2025-12-31 12686351 frs-bus:Director2 2025-01-01 2025-12-31 12686351 frs-bus:Director3 2025-01-01 2025-12-31 12686351 frs-countries:EnglandWales 2025-01-01 2025-12-31 12686351 2023-12-31 12686351 2024-12-31 12686351 2024-01-01 2024-12-31 12686351 frs-core:ShareCapital 2024-12-31 12686351 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31
Registered number: 12686351
CAERUS HEALTH LIMITED
ABRIDGED Financial Statements
For The Year Ended 31 December 2025
Brindley Jacob
Contents
Page
Abridged Balance Sheet 1
Notes to the Abridged Financial Statements 2
Page 1
Abridged Balance Sheet
Registered number: 12686351
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 100 100
Cash at bank and in hand 18,901 39,433
19,001 39,533
Creditors: Amounts Falling Due Within One Year (373 ) (360 )
NET CURRENT ASSETS (LIABILITIES) 18,628 39,173
TOTAL ASSETS LESS CURRENT LIABILITIES 18,628 39,173
NET ASSETS 18,628 39,173
CAPITAL AND RESERVES
Called up share capital 4 100 100
Profit and Loss Account 18,528 39,073
SHAREHOLDERS' FUNDS 18,628 39,173
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 December 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Miss Nicola Smith
Director
Mr Charles Wilkerson
Director
21/08/2026
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Abridged Financial Statements
1. General Information
CAERUS HEALTH LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 12686351 . The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: )
3 -
4. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
Page 2